Replies to post #114937 on NanoViricides Inc. (NNVC)

[changes_iv]

What about the competition to NanoVirircides, Inc. amazing technolgy? I know that not everyone can find that competition but certainly an experienced and knowledgeable anonymous poster like yourself, can! Yes, we can!...Yes, we can!...Yes, we can!...

There will always be a need and demand for vaccines, but many people won’t use them. We know this from experience. However, the existence of a nanoviricide treatment for a virus-borne illness means that treatment can begin after symptoms for influenza or some other virus-borne disease appear.

Based on animal studies, we believe that virus populations will be so reduced that symptoms would disappear in only a few hours. Immunity, however, would develop in the normal 21-day period so that the patient could not get the same infection again.

Some viruses—notably hepatitis, HIV, and herpes—might not be cleared entirely from the system because they hide inside various tissues. I believe, however, that symptoms will disappear, and the patient would not be contagious. When the virus emerges, however, it will encounter nanoviricides if they are in the patient’s system. Over time, there is a strong possibility that each reemergence will be smaller than the last, until the disease is gone. ~Mauldin Economics - Build Transformational Wealth from Three Tiny Companies

source: http://www.mauldineconomics.com/download/transformational-wealth-from-three-tiny-companies

============================================

Is this an example of a fact?

Miller and colleagues are hopeful that a universal flu vaccine will be a reality within the next 5-7 years.

Recently, MNT reported on a study from Columbia University's Medical Center and Mailman School of Public Health in New York, NY, that found text message reminders improved both first- and second-dose vaccination rates among young children.

Flu vaccine coverage remains low among young children overall. However, children who require two doses of vaccine in one season are at particular risk, the authors of that study observed, as less than half of these children return to receive a second dose after receiving their first.
http://www.medicalnewstoday.com/articles/288082.php

Is that with government "greased skids" and all?...and the promise of no contraindications, right?

Scientists find new evidence on GSK vaccine link to narcolepsy http://www.reuters.com/article/2015/07/01/us-health-narcolepsy-vaccine-idUSKCN0PB5PN20150701